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The endoplasmic reticulum(ER) is a multifunctional organelle within which protein folding,
lipid biosynthesis, and calcium storage occurs. Perturbations such as energy or nutrient
depletion, disturbances in calcium or redox status that disrupt ER homeostasis lead to
the misfolding of proteins, ER stress and up-regulation of several signaling pathways
coordinately called the unfolded protein response (UPR). The UPR is characterized by
the induction of chaperones, degradation of misfolded proteins and attenuation of protein
translation. The UPR plays a fundamental role in the maintenance of cellular homeostasis
and thus is central to normal physiology. However, sustained unresolved ER stress
leads to apoptosis. Aging linked declines in expression and activity of key ER molecular
chaperones and folding enzymes compromise proper protein folding and the adaptive
response of the UPR. One mechanism to explain age associated declines in cellular
functions and age-related diseases is a progressive failure of chaperoning systems. In
many of these diseases, proteins or fragments of proteins convert from their normally
soluble forms to insoluble fibrils or plaques that accumulate in a variety of organs including
the liver, brain or spleen. This group of diseases, which typically occur late in life includes
Alzheimer’s, Parkinson’s, type II diabetes and a host of less well known but often equally
serious conditions such as fatal familial insomnia. The UPR is implicated in many of
these neurodegenerative and familial protein folding diseases as well as several cancers
and a host of inflammatory diseases including diabetes, atherosclerosis, inflammatory
bowel disease and arthritis. This review will discuss age-related changes in the ER stress
response and the role of the UPR in age-related diseases.
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INTRODUCTION
Average life expectancies have been extended by as much as
30 years in developed countries during the Twentieth Century;
a trend that is expected to continue in this century (Vaupel et al.,
1998; Oeppen and Vaupel, 2002). The increase in elderly popu-
lations has raised interest in health consequences related to the
aging process. A multitude of diseases that seemed rare many
decades ago, are now amplified in aged individuals. Cases of
dementia and Alzheimer’s, incurable brain-wasting conditions,
are expected to almost double every 20 years to around 66 million
in 2030 and over 115 million in 2050 (Alzheimer’s Association,
2012).
Evidence has implicated a role for unfolded/misfolded pro-
teins in normal aging and age-related cognitive dysfunction.
Age-associated deterioration of cellular machinery leads to an
increase in the occurrence of protein misfolding, accumulation
and aggregation, due in part to the gradual decay of chaper-
oning systems (Macario and Conway de Macario, 2002). In the
majority of these diseases, proteins or protein fragments are trans-
formed from their native soluble forms into insoluble fibrils or
aggregated plaques that accumulate in a variety of organs. This
group of conformational disorders, which includes Alzheimer’s
disease (AD), Parkinson’s disease (PD), amyotrophic lateral scle-
rosis (ALS), Huntington’s disease, type 2 diabetes mellitus, and
a variety of other lesser known but equally severe conditions,
appear later in life and are associated with aging. The fact that
under normal physiological conditions, protein aggregates do not
accumulate in the cells is partially due to the presence of cellular
“quality control” mechanisms.
The endoplasmic reticulum (ER) contains one such system.
The ER suppresses aggregation by accurately ensuring transcrip-
tion and translation, chaperoning nascent or unfolded proteins,
and discerning then transporting improperly folded polypep-
tides through a degradation pathway before they can aggregate
(Ellgaard et al., 1999). Under conditions of stress, an adaptive
mechanism that includes a set of coordinated signaling pathways
termed the ER stress response or the unfolded protein response
(UPR) is activated with the goal of returning the ER to its normal
functioning state. In this review, we will examine key elements of
the ER stress response, their age-related modifications, the effects
of prolonged ER stress and the role of the ER stress response in
several pathological disorders, many of which have implications
for aging.
PROTEIN FOLDING AND QUALITY CONTROL
In general, protein folding is a staggeringly inefficient process
where some 30% of the proteins never acquire their fully folded
conformation (Romisch, 2004). The ER is a membrane bound
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compartment and the ER lumen is topologically equivalent to
the extracellular space. Its environment is highly oxidizing, which
makes it suitable for protein folding and maturation. In mam-
malian cells, protein folding occurs in three phases (Naidoo,
2011). First, co-translational and co-translocational folding tran-
spires as proteins traverse the ER membrane. After the release of
the completed polypeptide from the ribosome, post-translational
folding takes place.
Folding in the ER is the limiting step in the biogenesis of
most secretory and transmembrane proteins. Chaperones and
folding enzymes are engaged in all three folding stages. Key chap-
erones and folding sensors in the ER include: glucose regulated
proteins 78 (GRP78; also known as Immunoglobulin Binding
protein – BiP) and 94 (GRP94), the lectins, calnexin and calreti-
culin, and the thiol-disulfide oxidoreductases, protein disulfide
isomerase (PDI) and ERp57. These components reside in the ER
at high concentrations and participate in all stages of folding and
in quality control.
Aging reduces the efficacy of many of these chaperones
and foldases. Stringent restrictions on quality control within
the ER prevent incompletely assembled or improperly folded
proteins from exiting the ER and being transported to the
cytosol or to downstream organelles and terminal compart-
ments. Several abnormalities, including exposure of hydrophobic
regions, unpaired cysteines and the tendency to form aggregates,
will result in recognition of nascent proteins by the chaperones
and folding sensors, which will cause their retention within the
ER. Accumulation of misfolded proteins triggers ER stress and the
UPR (Berridge, 2002).
THE ER STRESS RESPONSE
Perturbations that alter ER homeostasis disrupt protein folding
and lead to the accumulation of unfolded proteins and/ aggre-
gates that trigger ER stress. ER stress can be provoked by a
variety of physiological conditions, including perturbations in
calcium homeostasis, glucose/energy deprivation, redox changes,
ischemia, hyperhomocystinemia, and viral infections and muta-
tions that impair client protein folding (Kaufman, 2002; Ron,
2002). As a consequence, the cell has evolved an adaptive coor-
dinated response to limit the accumulation of unfolded pro-
teins in the ER. These signaling pathways are collectively termed
the ER stress response or the UPR [for more detailed reviews
see (Zhang et al., 2001; Harding et al., 2002; Schroder and
Kaufman, 2005; Walter and Ron, 2011)]. On a cellular level, the
UPR triggers three kinds of protective cellular responses (see
Figure 1 schematic): (i) up-regulation of ER chaperones such as
BiP/GRP78 to assist in the refolding of proteins; (ii) attenuation
of protein translation which is mediated by the serine-threonine
kinase PERK which phosphorylates the initiation factor—eIF2α
thereby reducing translation; and (iii) degradation of misfolded
proteins by the proteasome by a process called ER associated
degradation (ERAD). PERK activation also upregulates an antiox-
idant response through NF-E2-related factor 2 (Nrf2) (Johnson
et al., 2008; Brown and Naidoo, 2010) (Figure 1). Nrf2 which
belongs to the cap “n” collar (CNC) subfamily of basic leucine
zipper transcription factors is known to play a significant role
in the adaptive stress response to oxidative stress (Venugopal
and Jaiswal, 1996; Itoh et al., 1999; He et al., 2001) and xenobi-
otic detoxification (Motohashi and Yamamoto, 2004). The three
UPR responses are protective measures to limit protein load
and alleviate ER stress; however, excessive and/prolonged stress
leads to a maladaptive response and apoptosis (Szegezdi et al.,
2006).
THE ER STRESS RESPONSE SIGNAL IS TRANSDUCED
BY 3 PROXIMAL SENSORS
ER stress signals are transduced across the ER membrane by
three proximal sensors of the UPR, inositol requiring element-1
(IRE-1), PKR like ER kinase (PERK) and activating transcription
factor 6 (ATF6). All three of these sensors are maintained in an
inactive state at the ERmembrane by binding to the ER chaperone
BiP (Immunoglobulin binding protein).
BiP is a peptide-dependent ATPase and member of the heat
shock 70 protein family that binds transiently to newly synthe-
sized proteins translocated into the ER, and more permanently
to underglycosylated, misfolded, or unassembled proteins. BiP is
also known as GRP78 and under the most recent nomenclature is
known as HSP5A (Heat shock protein 5A). Under non-stress con-
ditions BiP is bound to the three sensors ATF6, IRE1 and PERK,
preventing them from activating downstream events. Upon accu-
mulation of unfolded/ misfolded proteins, bound BiP dissociates
from ATF6, IRE1 and PERK to chaperone the misfolded pro-
teins thereby permitting the activation of one or more of these
transducers (Zhang and Kaufman, 2006).
PERK ACTIVATION LEADS TO THE ATTENUATIONOF PROTEIN
TRANSLATION
PERK is a type I transmembrane serine threonine kinase that
appears to be present in most cells. It is held in an inactive
monomeric state by binding to BiP. When this binding is dis-
rupted, PERK homodimerizes and phosphorylates itself, becomes
active and initiates its eIF2α kinase activity. Phosphorylation of
the translation initiation factor, eIF2α, results in the formation
of a stalled 43S ternary complex that causes a general decrease
in translation of most proteins. However, some selected proteins
with internal ribosomal entry sites (IRES), such as ATF4 and BiP,
are translated more efficiently (Harding et al., 2000) and hence
their protein levels actually increase.
ACTIVATION OF IRE-1 LEADS TO SPLICING OF XBP1
Once activated the cytoplasmic domain of IRE1α gains endori-
bonuclease activity and excises an intron from the mRNA encod-
ing an UPR-specific transcription factor, X-box binding protein
(XBP) 1, generating a spliced variant XBP1s. Spliced XBP1 func-
tions as a potent transcriptional transactivator of genes involved
in ER expansion, protein maturation, folding and export from
the ER, as well as export and degradation of misfolded proteins
(Yoshida et al., 2001; Calfon et al., 2002; Lee et al., 2002, 2003;
Yoshida et al., 2003). ER-bound mRNAs are also degraded in
an IRE1 dependent manner via a process called RIDD (“reg-
ulated IRE1-dependent decay”) and may serve to limit pro-
tein influx and unfolded protein load into the ER lumen after
prolonged UPR induction (Hollien and Weissman, 2006; Pirot
et al., 2007; Walter and Ron, 2011). Recent studies indicate an
Frontiers in Physiology | Integrative Physiology July 2012 | Volume 3 | Article 263 | 2
Brown and Naidoo ER stress response and aging
FIGURE 1 | Activation of the unfolded protein response (UPR).
Accumulation of misfolded or unfolded proteins in the ER leads to the
dissociation of BiP from 3 transducers –PERK, IRE1 and ATF6. PERK
homodimerizes and phosphorylates eIF2α to inhibit general protein
translation. PERK also regulates several transcription factors including,
NRF-2 to up-regulate the anti-oxidant response and ATF4 which can
lead to both protective and apoptotic signaling. IRE-1 activation
results in the unconventional splicing of XBP-1, which induces the
transcription of several molecular chaperones, such as BiP and GRP94
and stimulates protein degradation via ER-associated degradation (ERAD).
ATF6 is activated and cleaved and leads to induction of molecular
chaperones. The various ER chaperones are part of a protective adaptive
response that regulates protein folding and other components of
the UPR.
alternative model where IRE1 binds to unfolded proteins directly
and that these serve as activating ligands (Walter and Ron,
2011).
ACTIVATION OF ATF6 INCREASES THE TRANSCRIPTION OF
ER CHAPERONES
ATF6 is a 90-kDa bZIP protein that is activated by posttransla-
tional modifications. ATF6 activation as part of the UPR leads
to its translocation to the Golgi and cleavage by site-1 protease
(S1P) and S2P. The 50-kDa cleaved ATF6α translocates to the
cell nucleus, where it binds to the ER stress response element
CCAAT(N)9CCACG (Yoshida et al., 1998) in genes encoding ER
chaperone proteins such as BiP and GRP94. GRP94 is a mem-
ber of the heat shock90 family of chaperones. This binding results
in increases in the level of these proteins and hence increased
protein folding activity in the ER (Yoshida et al., 1998; Okada
et al., 2002). Other important targets regulated by ATF6 include
XBP-1, CHOP, HERP (hyperhomocysteinemia-induced ER stress
responsive protein) and PDI (Protein disulfide isomerase).
SUSTAINED ER STRESS LEADS TO AN
INFLAMMATORY RESPONSE AND APOPTOSIS
Prolonged ER stress leads to inflammatory signalingwhile unmit-
igated and excessive stress leads to apoptosis (Szegezdi et al., 2006;
Ron and Walter, 2007). Apoptosis in response to ER stress is
specific to metazoan cells (Schroder and Kaufman, 2005). When
cell protective changes mediated by the UPR fail to restore fold-
ing capacity, a combination of both the intrinsic and extrinsic
apoptotic pathways are activated (Schroder and Kaufman, 2005).
Apoptosis in response to ER stress is mediated largely by C/EBP
homologous protein (CHOP) also known as growth arrest and
DNA damage 153 (GADD 153). CHOP which is downstream
of the PERK and ATF6 pathways induces the expression of a
number of pro-apoptotic factors including Tribbles 3, GADD34
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and DR5. Bcl-2 family members (Bak/Bax), caspase-12 and c-
jun NH2 terminal kinase (JNK) are other components of the
ER stress mediated apoptotic pathway (Wu and Kaufman, 2006)
(Figure 2).
JNK activation, which occurs through IRE1 dependent sig-
naling, induces the expression of inflammatory genes by phos-
phorylation of AP1 (transcription activator protein 1) (Davis,
2000; Zhang and Kaufman, 2008). NF-kappa B (NF-κB) depen-
dent transcription is increased two ways during ER stress. First,
I kappa K (IKK) which has a shorter half life is reduced when
protein translation is attenuated thereby changing the stoichio-
metric ratio of NF-κB: IKK and freeing NF-κB to translo-
cate to the nucleus (Zhang and Kaufman, 2008). Secondly,
the IRE1-TRF2 complex recruits I kappa B (IKB) kinase that
phosphorylates IKB and leads to its degradation (Hu et al.,
2006).
AGE-RELATED CHANGES IN THE ER STRESS RESPONSE
UPR COMPONENTS DECLINE WITH AGE
During aging, there is a shift in the balance between the protec-
tive adaptive response of the UPR and pro-apoptotic signaling;
where the protective arm is significantly reduced and the apop-
totic arm is more robust (Paz Gavilan et al., 2006; Hussain and
Ramaiah, 2007; Naidoo et al., 2008). Key ER resident chaperones
and enzymes within the ER such as BiP, PDI, calnexin andGRP94,
which are required for proper protein folding, are impaired dur-
ing the aging process. Chaperones are progressively oxidized with
age and this process may contribute to their functional decline.
These alterations in oxidation significantly correlate with reduc-
tions in enzymatic activity of several chaperones (Nuss et al.,
2008).
BiP expression levels are significantly reduced in several species
with age. In the cerebral cortex of aged (22–24-month old)
FIGURE 2 | Sustained ER stress leads to pro-apoptotic signaling
and cell death. Unresolved ER stress leads to inflammation and cell death
pathways involving the PERK and IRE1 branches of the UPR. The
IRE1-TRAF2- apoptosis signaling kinase 1 (ASK1) complex upregulates
c-jun NH2 terminal kinase (JNK) and caspases and through splicing of XBP1
can activate C/EBP homologous protein (CHOP), a pro-apoptotic transcription
factor. PERK signaling, through phosphorylation of eIF2α, can activate
ATF4 dependent transcription resulting in activation of nuclear factor-kappaB
(NFκB) and increases in CHOP. CHOP and ER specific caspases are
thought to directly induce cell death. Several genes that mediate
apoptotic function and inflammation are induced by prolonged
ER stress.
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C57/B6 mice compared with that in young (3-month old) mice,
BiP protein levels were decreased 30% (Naidoo et al., 2008). BiP
mRNA and protein expression levels are also decreased in the hip-
pocampus of aged (23–26-month old) versus young (4–6-month
old) Wistar rats (Paz Gavilan et al., 2006). A study that exam-
ined BiP protein expression in the brain (cortex and cerebellum)
and in peripheral tissue (lung, liver, kidney, heart, and spleen)
of Wistar rats across their life span found that expression of BiP
was higher in the young tissue in comparison to the aged tissue
(Hussain and Ramaiah, 2007).
Age modifies other components of the UPR in addition to the
chaperones and enzymes. PERKmRNA was significantly reduced
in the hippocampus of aged rats (Paz Gavilan et al., 2006).
Another study reported that the activity of PKR (double stranded
RNA-dependent kinase), an eIF2α kinase, was less efficient when
isolated from aged rat brain tissue (Hussain and Ramaiah, 2007)
than similar tissue isolated from young rats. Accompanying the
declines in PERK signaling are increases in GADD34, which
removes the translational block imposed by eIF2α phosphoryla-
tion. Increases in the expression of GADD34 were found in the
cortical tissue of agedmice. Suppression of the translational block
by GADD34 allows for the synthesis of pro-apoptotic proteins like
CHOP.
Both basal and inducible CHOP expression levels are elevated
with age (Kirkland et al., 2002; Ikeyama et al., 2003). Expression
of CHOP and caspase-12, another pro-apoptotic molecule, was
induced in aged rats that were stressed, but not in the young
stressed animals (Paz Gavilan et al., 2006), lending support to
the idea that the aged animals are more vulnerable to apopto-
sis. Studies from our laboratory demonstrate the upregulation of
CHOP in aged mouse cortex (Naidoo et al., 2008) as others have
shown in aged rat hippocampus (Paz Gavilan et al., 2006) and in
aged rat cortex (Hussain and Ramaiah, 2007).
JNK kinases are also upregulated during aging. They are signal
transduction proteins that regulate gene expression through the
phosphorylation of transcription factors such as c-Jun and ATF-2.
JNK is also activated by the kinase domain of IRE1 through the
TNF receptor-associated factor 2 (TRAF2) and apoptosis signal-
regulating kinase 1 (ASK1) (Ichijo et al., 1997; Szegezdi et al.,
2006), which contributes to the induction of apoptosis.
STRUCTURAL CHANGES
There are also structural changes in the ER with age. Hinds and
McNelly, have demonstrated that the highly ordered parallel cis-
ternae of rough ER characteristic of young neurons seems to
become dispersed during aging (Hinds andMcNelly, 2005). They
have quantitatively measured this dispersion of the aging, rough
ER cisternae in both mitral cells in the olfactory bulb and in
Purkinje cells and found that there is a highly linear decrease
in the measured closeness of rough ER cisternae throughout
adult life. The age-related declines of important UPR chaperones,
enzymes and ER structure significantly affect the efficiency of
managing proper protein folding and ultimately ER homeostasis.
AUTOPHAGY
The UPR activates autophagy in order to remove aggregates of
misfolded proteins that cannot be degraded by the ERADpathway
(Ogata et al., 2006). Evidence suggests that autophagy can pro-
vide neuroprotection by enhancing clearance of these aggregates.
Growing evidence indicates that autophagy also declines with
age; the rate of autophagosome formation and maturation and
the efficiency of autophagosome/lysosome fusion are reduced
(Rajawat and Bossis, 2008). Dysregulation of the autophagic pro-
cess may lead to neurodegeneration (Nedelsky et al., 2008). There
are several excellent reviews that explore the relationship between
ER stress, the UPR, autophagy and neurodegenerative disorders
(Matus et al., 2008; Doyle et al., 2011).
THE ER STRESS RESPONSE IN AGE-RELATED DISEASES
METABOLIC DISORDERS AND TYPE 2 DIABETES
The ER, which regulates protein synthesis and secretion as well
as triglyceride and cholesterol biosynthesis and controls cellu-
lar metabolism, has been postulated to be a site for sensing
metabolic stress. Recent data from experimental models indicate
that ER stress is critical to the initiation and integration of path-
ways of inflammation and insulin action in metabolic syndrome
(Hotamisligil, 2006). Metabolic syndrome which encompasses
insulin resistance, reduced glucose utilization and type 2 diabetes
are regulated by numerous mechanisms, including the UPR, JNK
activation, NF-κB activation and apoptosis (Hotamisligil, 2006).
The two principal inflammatory pathways that disrupt insulin
action, JNK–AP-1 and IKK–NF-κB, are linked to IRE-1 and PERK
activity during ER stress (Deng et al., 2004). IRE-1 is linked to
activation of JNK through a pathway involving TNF-receptor-
associated factor 2 (Urano et al., 2000). Activation of both IRE-1
and PERK is also linked to the IKK–NF-κB pathway, through
distinct mechanisms as described in the section above.
Insulin-receptor substrate 1 (IRS1), which transmits the effects
of insulin through interactions with other cytosolic molecules
is phosphorylated by activated insulin receptors on tyrosine
residues. It is thought that JNK-mediated phosphorylation of
serine residues in IRS1 inhibits the phosphorylation of IRS1 on
tyrosine residues and leads to insulin resistance (Aguirre et al.,
2002; Zhang and Kaufman, 2008).
SLEEP
It is becoming increasingly evident that sleep disruption leads
to the ER stress response. Several studies have shown that acute
sleep deprivation induces the up-regulation of BiP/GRP78 in the
brains of mice (Naidoo et al., 2005; Mackiewicz et al., 2007), rats
(Cirelli et al., 2004), birds (Jones et al., 2008) and fruitflies (Shaw
et al., 2000; Naidoo et al., 2007). We have demonstrated that
the PERK pathway is activated with six or more hours of sleep
loss in the cerebral cortex of mouse brain (Naidoo et al., 2005).
PERK cerebellar transcript levels were also found to be higher in
wakefulness than in sleep (Cirelli et al., 2004). Other UPR spe-
cific transcripts that change with sleep deprivation include DNA-J
which is a co-chaperone of BiP, XBP-1, calreticulin, caspase-9,
ATF4 and ATF6.
Not only is the ER stress response activated with sleep loss
it appears to be involved in the sleep homeostatic response.
In Drosophila there is an increase in BiP with sleep loss and
a diminution of expression with recovery sleep (Naidoo et al.,
2007). BiP protein levels return to baseline levels over 24 h with
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recovery sleep following an almost 3-fold increase with 6 h of
sleep deprivation. Over expression of BiP through genetic means
leads to an increase in the amount of sleep recovered after sleep
loss. Whether the altered amounts of recovery sleep when BiP lev-
els are manipulated is due to BiP itself or more indirectly through
other effects on the UPR remains to be determined.
Changes with age
Aged animals exhibit more fragmented sleep (Welsh et al., 1986;
Shiromani et al., 2000; Naidoo et al., 2008) and display basal lev-
els of ER stress in tissues examined (Naidoo et al., 2011). The
adaptive ER stress response to sleep deprivation is impaired in
aged mice cerebral cortices (Naidoo et al., 2008). There is little
evidence of BiP up-regulation and attenuation of protein trans-
lation. Orexin and noradrenergic neurons in aged mice display
considerable ER stress with activation of the PERK pathway when
compared with similar regions in young mice (Naidoo et al.,
2011). Surprisingly, recovery sleep following sleep deprivation
is less in older animals than young. This has been shown in
humans (Bonnet, 1985; Carskadon and Dement, 1987) and in
rats (Mendelson and Bergmann, 2000; Shiromani et al., 2000).
It is not known whether the UPR plays a role in the mammalian
recovery sleep response to sleep deprivation and is currently being
investigated.
NEURODEGENERATIVE DISEASES
ER stress and activation of the UPR has been implicated in abnor-
mal protein processing and neuronal death in age-associated
diseases, which subsequently play a role in the pathogenesis
of neurodegenerative diseases (see reviews Forman et al., 2003;
Johnson et al., 2008). These diseases, which include Alzheimer’s
disease, Parkinson’s disease, ALS and Huntington’s disease, nor-
mally appear later in life and are thus associated with the aging
process. Neuronal loss in both familial and sporadic forms of
neurodegenerative disorders is often accompanied by aggrega-
tion of misfolded proteins (Selkoe, 2003). Studies have suggested
that initial participation of the UPR in neurodegenerative dis-
orders is probably cytoprotective, however, when activation of
the UPR is sustained over an extended period of time, apoptotic
pathways are upregulated. Accumulation of misfolded proteins
that lead to alterations in organelle structure including the ER
has been described in transgenic models of ALS, Alzheimer’s
and Huntington’s disease (Reddy et al., 1999; Rao et al., 2002).
Like many other signaling pathways, the UPR suffers from age-
related impairments and becomes less effective (Naidoo et al.,
2008).
Although many studies found activation of the UPR in neu-
rodegenerative diseases, the studies are conflicting on whether
there is induction of BiP. One study shows that BiP, along with
other UPR markers were increased in the neurons of AD patients
versus the non-demented controlled individuals (Hoozemans
et al., 2005). Another study, on the other hand, found activa-
tion of the UPR, as measured by analyzing XBP-1 mRNA splicing
along with activation of pro-apoptotic factors such as CHOP and
caspases-3, 4, and 12; however, these authors show no induction
of BiP expression (Lee et al., 2010). The conflict in each of these
reports could be marked differences in the basal levels of BiP.
Lee et al. showed that UPR activation could be separated from
amyloid β (Aβ) burden in the Tg2576 mice. Levels of PDI and BiP
were similar in the cortex of aged Tg2576 and wild type mice (Lee
et al., 2010). The authors suggest that Aβ burden alone is insuf-
ficient for induction of the UPR. This too is controversial, and
rather ambiguous, since others have found that amyloid beta (Lee
do et al., 2010; Costa et al., 2011), oligomeric not fibrillar, induces
ER stress (Chafekar et al., 2007). A Drosophila model showed
that neurotoxicity of tau was significantly increased when levels of
XBP1 were reduced (Loewen and Feany, 2010). An earlier study,
however, found that in an ALS murine model expressing mutant
superoxide dismutase, removing XBP1 was neuroprotective, pre-
sumably through activation of an autophagic response (Hetz
et al., 2009). P-PERK and P-IRE1 were found to be upregulated
in response to early tau pathology (Nijholt et al., 2012).
Involvement of the UPR in Parkinson’s disease (PD) has been
described primarily in cellularmodels using drugs thatmimic cer-
tain aspects of PD (Ryu et al., 2002; Smith et al., 2005). Parkin, an
ubiquitin-protein ligase, is up-regulated in response to unfolded
protein stress and suppresses cell death via its E3 activity. Loss
of parkin function results in the misfolding and accumulation of
PAEL-R, a substrate of parkin in the ER of substantia nigra neu-
rons, leading to ER stress and cell death (Imai et al., 2001). This
process has been proposed to be responsible for neuronal cell
death in autosomal recessive juvenile parkinsonism and it sug-
gests a physiological role of Parkin in dealing with ER stress (Imai
et al., 2001). In addition, overexpression of wild-type or mutant
α-synuclein induces UPR activation in yeast (Cooper et al., 2006).
A study performed by Hoozemans and colleagues demonstrated
activation of the PERK–eIF2a pathway in dopaminergic neurons
in the substantia nigra of PD cases (Hoozemans et al., 2007).
These varied studies suggest that targeting the UPR, whether by
activation or inhibition, may provide opportunities for therapeu-
tic intervention in several neurodegenerative disorders.
ATHEROSCLEROSIS AND HYPERHOMOCYSTEINEMIA
Evidence suggests that ER stress and the UPR can mediate
the pathogenesis of atherosclerosis and vascular inflammation
(Zhang and Kaufman, 2008; Santos et al., 2009). Atherosclerosis is
a progressive disease of the large arteries where lipids and proteins
derived from circulating low-density lipoproteins (LDL) accumu-
late within the cells and in the extracellular space (Ursini et al.,
2002). There are a variety of methods in which ER function may
influence the development of atherosclerosis. First, many criti-
cal lipid biosynthetic pathways are located in the ER (Gregor and
Hotamisligil, 2007). Secondly, ER stress has been found to drive
free-cholesterol-induced apoptosis in macrophages in a model of
cellular free-cholesterol loading (Tabas, 2009). This suggests that
the ERmay sense stress related to lipid status and exposure, result-
ing in the passage of information to signaling pathways involved
in inflammation and death in cells that are key in the develop-
ment of atherosclerosis (Tabas, 2009). Finally, the UPR may have
an important function in adaptive immunity. Substantial evi-
dence indicates that autoimmune events mediated by ER stress
may contribute to atherosclerosis (for a more detailed commen-
tary on this subject see G. S. Hotamisligil, NatureMedicine, 2010)
(Hotamisligil, 2010a,b).
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Hyperhomocysteinemia (HHcy) is a common, indepen-
dent risk factor for the development of cardiovascular disease.
Epidemiological studies have found associations between high
levels of serum homocysteine and the development of ischemic
heart disease and stroke (Eikelboom et al., 1999); however,
whether homocysteine is the underlying cause of atherosclero-
sis and thrombosis is not known. It was reported in cultured
vascular endothelial cells that homocysteine induced protein mis-
folding in the ER by interfering with disulfide bond formation.
This leads to activation of the UPR as the induction of several
ER stress response proteins, such as BiP, GRP94, CHOP and
HERP were found (Outinen et al., 1999; Huang et al., 2001).
Homocysteine was also shown to activate apoptosis in an IRE1-
dependent manner (Zhang et al., 2001). HHcy activates cleavage
of the sterol regulatory element binding protein (SREBP), which
leads to intracellular accumulation of cholesterol (Ron, 2001).
Overexpression of BiP, which attenuates ER stress, suppresses
this activation, implicating the UPR in the process (Kammoun
et al., 2009; Basseri and Austin, 2012). The role of ER stress in
atherosclerosis and other forms of cardiovascular disease likely
involves an integrated network of multiple signaling pathways,
including, but not limited to inflammation and lipid metabolism.
THE ROLE OF THE UPR IN CANCER
Cancer rates increase sharply with age in both sexes, with the
majority of cases occurring in patients over the age of 65 (Burkle
et al., 2007). Recent studies in the cancer field have clearly demon-
strated that ER stress and the UPR are robustly upregulated in
various tumor types and are closely associated with cancer cell
survival and their resistance to anti-cancer treatments (Wang
et al., 2010). Researchers are now examining what markers of
the UPR pathway are either induced or suppressed in malig-
nancy in the hope of targeting these specific components for
treatment. Tumor formation results in the high proliferation of
cancer cells. During this process, a burden is placed on the ER
that requires increased activities of protein folding, assembly and
transport leading to physiological ER stress (Lee, 2007). As the
tumor increases, the cancer cells are exposed to nutrient depriva-
tion and hypoxic conditions; which are well known inducers for
the accumulation and aggregation of unfolded and/or misfolded
proteins in the ER, resulting in activation of the UPR pathways
(Lee, 2007; Luo et al., 2009).
Evidence suggest that the adaptive arm of the UPR provides
survival signaling pathways that are conducive to the growth of
tumors, while suppressing the apoptotic arm of the UPR that
would contribute to cell death and normal growth. Cancer cells
may evade the apoptotic pathways by differentially activating the
UPR branches (Pyrko et al., 2007; Hersey and Zhang, 2008). BiP
has been shown to be upregulated in several different types of
cancers (Zhang and Zhang, 2010) and is implicated in playing a
critical cytoprotective role in oncogenesis (Li and Lee, 2006; Healy
et al., 2009). BiP expression levels have been positively correlated
with cerebral tumor malignancy, i.e., the higher the BiP levels, the
more malignant the tumor (Zhang and Zhang, 2010). Previous
reports found that BiP afforded protection against a variety of
chemotherapeutic drugs that included: adriamycin, etoposide,
5-FU and temozolomide (Reddy et al., 2003; Fu et al., 2007; Lee,
2007; Pyrko et al., 2007). Later studies found that BiP was able
to confer chemoresistance to tumor-associated endothelial cells
(Virrey et al., 2008).
It has been reported by several groups that knocking down
or interfering with BiP function, sensitizes tumors to treatment.
Wang et al found that (-)-epigallocatechin gallate (EGCG), a
natural inhibitor of BiP that targets its ATP-binding domain,
sensitizes breast cancer cells to taxol and vinblastine, two broad
cytotoxic drugs (Wang et al., 2009). Another study found that
down-regulation of BiP by small interfering RNA decelerates
glioma cell growth (Pyrko et al., 2007).
Other components of the UPR are also activated in can-
cer. When the spliced variant of XBP1 was expressed in IRE1α
dominant-negative expressing cells angiogenesis was restored
(Romero-Ramirez et al., 2009), suggesting that signaling through
the IRE1α-XBP1 arm of the UPR is essential for angiogenesis in
the early stage of tumor development.
The PERK-eIF2α branch of the UPR has been shown to pro-
tect cells under conditions of hypoxia; a feature common to solid
tumors that is the result of increased demands on energy require-
ments due to dysregulated cell growth (Wouters and Koritzinsky,
2008). Hypoxic conditions can induce PERK, leading to phos-
phorylation of eIF2α in tumor cells (Koumenis et al., 2002; Fels
and Koumenis, 2006). Evidence supporting the role of the UPR in
cancer offers some interesting therapeutic alternatives for cancer
treatment. Approaches to induce and/or prevent UPR activation
in oncogenesis could have implications for improving therapeutic
outcomes.
OTHER AGE-RELATED INFLAMMATORY DISEASES
Besides the well known age–related diseases and disorders dis-
cussed above, ER stress has been implicated in several chronic
diseases involving inflammation (Hotamisligil, 2010a,b). These
include neuromuscular inflammatory diseases, arthritis and
spondyloarthropathies, multiple forms of respiratory inflamma-
tion and inflammatory bowel diseases (Hybiske et al., 2007;
Mhaille et al., 2008; Colbert et al., 2010; McGuckin et al., 2010).
In many of these diseases, it is not yet clear whether ER stress
is a primary contributor to the disease or a consequence of the
condition. It has been suggested that, in some circumstances, ER
stress can initiate disease but that inflammation, in some cases
owing to infection, is an important exacerbator of ER stress and
can be the trigger for the onset of disease in a genetically sus-
ceptible individual [for more information see review by (Hasnain
et al., 2012)]. Increasing evidence links ER stress to inflamma-
tory bowel disease. Secretory epithelial cells that produce anti-
microbial molecules and the mucus barrier, which separate the
epithelium from the luminal microbes, are very vulnerable to
ER stress (Hasnain et al., 2012). These cells produce the high
molecular weight cysteine rich mucins that are prone to misfold-
ing. Genetic studies in rodent models indicate that deficiencies
in the UPR pathway lead to spontaneous intestinal inflammation
(Heazlewood et al., 2008).
CONCLUDING REMARKS
The ER stress response comprises a complex set of signaling
pathways that serves to maintain ER and protein homeostasis
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in response to genetic, host (hypoxia, ATP, calcium alterations),
microbial and inflammatory stressors. With age, many of the
components of the UPR decline and become less efficient thus
dampening the response to these stressors. This results in or exac-
erbates existing diseases. Therapeutics that reduce ER stress by
promoting correct folding of proteins, improving the efficiency of
ERAD and/or enhancing the detection of misfolded proteins may
prove useful in delaying or preventing some of the age-related
diseases and disorders discussed in this review. Also, recognizing
perturbations in the ER stress response could lead to early detec-
tion of a number of age-related pathologies and the development
of therapeutics which maintain a normal ER stress response later
in life. This represents a hitherto unexplored avenue to disease
prevention.
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